These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8706035)

  • 1. Use of gene marking in bone marrow transplantation.
    Heslop HE; Rooney CM; Rill DR; Krance RA; Brenner MK
    Cancer Detect Prev; 1996; 20(2):108-13. PubMed ID: 8706035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity].
    Schrøder H; Clausen N; Thorling K; Hokland P
    Ugeskr Laeger; 1993 May; 155(20):1536-9. PubMed ID: 8316985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of marker genes into hemopoietic progenitor cells.
    Brenner MK; Heslop HE; Rill D; Li C; Smith C; Krance R; Rooney C
    Cytokines Mol Ther; 1996 Sep; 2(3):193-200. PubMed ID: 9384704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.
    Garcia-Castro J; Rio P; Lillo R; Garcia-Sanchez F; Segovia JC; Bueren JA
    Gene Ther; 2003 Aug; 10(16):1328-35. PubMed ID: 12883529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gene marking technologies in oncology.
    Brenner M
    Forum (Genova); 1998; 8(4):342-53. PubMed ID: 9863029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene marking to improve the outcome of autologous bone marrow transplantation.
    Brenner MK; Rill DR
    J Hematother; 1994; 3(1):33-6. PubMed ID: 7922006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Barnett L; Heller G
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsuccessful CTL transfusion in a case of post-BMT Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD).
    Imashuku S; Goto T; Matsumura T; Naya M; Yamori M; Hojo M; Hibi S; Todo S
    Bone Marrow Transplant; 1997 Aug; 20(4):337-40. PubMed ID: 9285550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of marker gene studies to hemopoietic stem cell therapies.
    Brenner MK
    Stem Cells; 1995 Sep; 13(5):453-61. PubMed ID: 8528094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene marking to improve the outcome of autologous bone marrow transplantation.
    Brenner MK; Rill DR
    Prog Clin Biol Res; 1994; 389():587-91. PubMed ID: 7700924
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus-related lymphoproliferative disease complicating childhood acute lymphoblastic leukemia: no recurrence after unrelated donor bone marrow transplantation.
    Pondarré C; Kebaili K; Dijoud F; Basset T; Philippe N; Bertrand Y
    Bone Marrow Transplant; 2001 Jan; 27(1):93-5. PubMed ID: 11244444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.
    Rill DR; Moen RC; Buschle M; Bartholomew C; Foreman NK; Mirro J; Krance RA; Ihle JN; Brenner MK
    Blood; 1992 May; 79(10):2694-700. PubMed ID: 1316784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
    Tam YK; Klingemann HG
    Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.